Stocks ended mixed Friday, with consumer and technology shares
rebounding just enough to lift the Nasdaq Composite index back to
positive territory by the close. Shares slumped at mid-day, giving
back earlier advances that followed tame inflation data, after
reports of renewed fighting in Ukraine hit. Questions over Russian
intentions with its supposed aid convoy also influenced commodity
prices. Gold rose in haven-shopping and crude oil and wheat futures
climbed on supply concerns.
The Commerce Department today said producer prices rose only
0.1% in July, meeting expectations, and falling from an unrevised
0.4% gain the previous month. Excluding the food and fuel, the
producer price index rose an as-expected 0.2% last month and
follows a downward revision in June to a 0.1% rise.
Crude oil for September delivery rose $1.77 to $97.35 a share
while September natural gas fell 13 cents to finish at $3.78 per 1
million BTU. December gold fell $9.40 to settle at $1,304.50 per
ounce, giving back earlier gains in haven-shopping. September
silver slid 38 cents to finish at $19.49 per ounce while September
copper rising 12 cents to $3.09 per pound.
Here's where the U.S. markets stood at the end-of-day:
Dow Jones Industrial Average down 50.67 (-0.30%) to
S&P 500 down 0.12 (-0.01%) to 1,955.06
Nasdaq Composite Index up 11.92 (+0.27%) to 4,464.93
Hang Seng Index up 0.62%
Shanghai China Composite Index up 0.92%
FTSE 100 Index up 0.06%
(+) MNST, Enters long-term strategic partnership with Coca-Cola
), which will buy 16.7% stake in MNST for $2.15 bln. The deal
includes KO contributing its energy portfolio to MNST, which will
contribute its non-energy portfolio to KO.
(+) ACHN, Reports interim results from Phase II trial of its
ACH-3102 drug candidate, with all 12 patients taking the drug
combined with Gilead Sciences (
) Sovaldi Hep C treatment showed no detectable traces of the virus
after four weeks.
(+) AMCF, Crushes lone analyst estimate for Q2 revenue, posting
a 131.7% jump in sales during the three months ended June 30 of
$175.5 mln. Net income of $2.9 mln, or $0.28 per share, reverses
$79,414 net loss last year.
(-) LAD, Reduced to Underweight at Morgan Stanley.
(-) WB, Trims Q2 loss, matching Street view. Offers strong Q3
(-) ICPT, FBR Capital assigns Underperform rating with a $172